An In Vitro Evaluation of a New Approach in AMD: Effects of the Combination of Resveratrol and Anti-VEGFs on ARPE-19 Cells
Biomolecules · 2026
DOI: 10.3390/biom16060883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Onur Konukcu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Süleyman Demirel University Research and Education Hospital, Isparta TR-32260, Türkiye. Hauptthemen laut MEDLINE: Resveratrol, Macular Degeneration, Vascular Endothelial Growth Factor A, Ranibizumab. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Süleyman Demirel University.
Abstract (Originalsprache)
Anti-vascular endothelial growth factor agents (anti-VEGFs) are the cornerstone of treatment for neovascular age-related macular degeneration (AMD). Resveratrol is a natural polyphenol with well-established antioxidant and anti-apoptotic properties. This study investigated whether resveratrol exerts cytoprotective effects when combined with anti-VEGFs on ARPE-19 cells in vitro. Cells were treated with ranibizumab (RNZ), aflibercept (AFL), or ziv-aflibercept (ZFL), either alone or in combination with resveratrol. Mitochondrial and cytosolic reactive oxygen species (MitROS and CytROS), mitochondrial membrane depolarization (MitDep), caspase-3, -8 and -9 activities, cell viability, apoptosis, and VEGF-A levels were evaluated using confocal microscopy, plate reader-based assays, and ELISA techniques. Anti-VEGFs induced tolerable oxidative or apoptotic stress in ARPE-19 cells but did not exhibit intrinsic antioxidant and cytoprotective effects. The addition of resveratrol significantly enhanced beneficial effects by reducing oxidative stress, preserving mitochondrial integrity, and suppressing intrinsic apoptotic signalling, while increasing cell viability. VEGF-A levels were effectively reduced by anti-VEGF treatment, and this suppression was further augmented by resveratrol without compromising cellular survival. These findings indicate that resveratrol acts as an additive modulator that strengthens the cellular effects of anti-VEGFs on ARPE-19 cells. The combination strategy may represent a supportive approach to optimize long-term anti-VEGF therapy in AMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Süleyman Demirel University Research and Education Hospital, Isparta TR-32260, Türkiye.
- Department of Biophysics, Faculty of Medical, Suleyman Demirel University, Isparta TR-32260, Türkiye.
- Neuroscience Research Center, Suleyman Demirel University, Isparta TR-32260, Türkiye.
- Drug Discovery Unit, BSN Health, Analyses, Innovation, Consultancy, Organization, Agriculture and Industry Ltd., Göller Bölgesi Teknokenti, Isparta TR-32260, Türkiye.
ORCID-Profile: Mehmet Argun, Semra Acer, Ömer Çelik, Mustafa Nazıroğlu
Förderung
- Süleyman Demirel University
Zitieren
APA
Konukcu, O., Argun, M., Acer, S., Çelik, Ö., Tök, Ö., Tök, L., & Nazıroğlu, M. (2026). An In Vitro Evaluation of a New Approach in AMD: Effects of the Combination of Resveratrol and Anti-VEGFs on ARPE-19 Cells. Biomolecules. https://doi.org/10.3390/biom16060883
Vancouver
Konukcu O, Argun M, Acer S, Çelik Ö, Tök Ö, Tök L, et al. An In Vitro Evaluation of a New Approach in AMD: Effects of the Combination of Resveratrol and Anti-VEGFs on ARPE-19 Cells. Biomolecules. 2026. doi:10.3390/biom16060883
BibTeX
@article{Konukcu2026,
author = {Konukcu, Onur and Argun, Mehmet and Acer, Semra and Çelik, Ömer and Tök, Özlem and Tök, Levent and Nazıroğlu, Mustafa},
title = {An In Vitro Evaluation of a New Approach in AMD: Effects of the Combination of Resveratrol and Anti-VEGFs on ARPE-19 Cells},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16060883}
}
EUVIMED